Cellerant Therapeutics, Inc. (Cellerant)

Oncology Corporate Profile

HQ Location

1561 Industrial Road
San Carlos, CA 94070

Company Description

Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008, is under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML. The Company also has a cancer stem cell antibody discovery program focused on therapies for acute myeloid leukemia, multiple myeloma and myelodysplastic syndrome.

Website: http://www.cellerant.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CLT-008immunotherapyAcute Myelogenous Leukemia (AML)II
CLT-009immunotherapyVarious cancer typesII

View additional information on product candidates here »

Source: http://www.cellerant.com

Recent News Headlines

There are no news items to display